ABOS: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, ABOS has $142,221K in assets. $49,048K in debts. $46,832K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Cash and cash equivalents	46,832	36,810
Marketable securities, short-term	79,777	106,559
Prepaid expenses and other current assets	5,544	5,035
Total current assets	132,153	148,404
Marketable securities, long-term	9,443	22,797
Restricted cash	232	232
Other assets, long-term	393	464
Total assets	142,221	171,897

Accounts payable	682	2,103
Accrued clinical trial expenses	9,884	11,108
Accrued expenses and other current liabilities	7,792	11,650
Debt, short-term	3,598	-
Total current liabilities	21,956	24,861
Debt, long-term	27,053	29,882
Other liabilities, long-term	39	77
Total liabilities	49,048	54,820
Common stock, 0.0001 par value 300,000,000 shares authorized as of september30, 2025 and december31, 2024 60,573,425 and 60,094,083 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively	6	6
Additional paid-in capital	514,382	511,921
Accumulated deficit	-421,324	-394,873
Accumulated other comprehensive income (loss)	109	23
Total stockholders equity	93,173	117,077
Total liabilities and stockholders equity	142,221	171,897